Cargando…

Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass

OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd editio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumoto, Muneto, Suzuki, Eiji, Nagata, Mayumi, Suzuki, Keisuke, Hirata, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076141/
https://www.ncbi.nlm.nih.gov/pubmed/35989269
http://dx.doi.org/10.2169/internalmedicine.0132-22
_version_ 1785020072835678208
author Tatsumoto, Muneto
Suzuki, Eiji
Nagata, Mayumi
Suzuki, Keisuke
Hirata, Koichi
author_facet Tatsumoto, Muneto
Suzuki, Eiji
Nagata, Mayumi
Suzuki, Keisuke
Hirata, Koichi
author_sort Tatsumoto, Muneto
collection PubMed
description OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd edition (beta version), migraine causes hypersensitivity, especially photosensitivity, during attacks, suggesting that light is an inducer of headaches. We developed Blue Cut for Night (BCN) glass, which reduces light stimulation to intrinsically photosensitive continental ganglion cells (ipRGCs), photoreceptors that can lead to exacerbation of migraine attacks. METHODS: Ten patients with migraine participated in the study. Each participant was made to wear BCN glasses only at night for four weeks. The number of headache days and Headache Impact Test-6 values before and after using the BCN glasses were compared. RESULTS: When the 10 patients with migraine wore the BCN glass at night only for 4 weeks, the number of headache days within that time tended to decrease (7.0±4.37 days) compared to before wearing the glasses (8.7±5.03 days). No participants had any side effects. CONCLUSION: BCN glass, which reduces light stimulation to ipRGCs, was suggested to be a tool for reducing migraine attacks.
format Online
Article
Text
id pubmed-10076141
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-100761412023-04-06 Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass Tatsumoto, Muneto Suzuki, Eiji Nagata, Mayumi Suzuki, Keisuke Hirata, Koichi Intern Med Original Article OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd edition (beta version), migraine causes hypersensitivity, especially photosensitivity, during attacks, suggesting that light is an inducer of headaches. We developed Blue Cut for Night (BCN) glass, which reduces light stimulation to intrinsically photosensitive continental ganglion cells (ipRGCs), photoreceptors that can lead to exacerbation of migraine attacks. METHODS: Ten patients with migraine participated in the study. Each participant was made to wear BCN glasses only at night for four weeks. The number of headache days and Headache Impact Test-6 values before and after using the BCN glasses were compared. RESULTS: When the 10 patients with migraine wore the BCN glass at night only for 4 weeks, the number of headache days within that time tended to decrease (7.0±4.37 days) compared to before wearing the glasses (8.7±5.03 days). No participants had any side effects. CONCLUSION: BCN glass, which reduces light stimulation to ipRGCs, was suggested to be a tool for reducing migraine attacks. The Japanese Society of Internal Medicine 2022-08-20 2023-03-15 /pmc/articles/PMC10076141/ /pubmed/35989269 http://dx.doi.org/10.2169/internalmedicine.0132-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Tatsumoto, Muneto
Suzuki, Eiji
Nagata, Mayumi
Suzuki, Keisuke
Hirata, Koichi
Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
title Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
title_full Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
title_fullStr Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
title_full_unstemmed Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
title_short Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass
title_sort prophylactic treatment for patients with migraine using blue cut for night glass
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076141/
https://www.ncbi.nlm.nih.gov/pubmed/35989269
http://dx.doi.org/10.2169/internalmedicine.0132-22
work_keys_str_mv AT tatsumotomuneto prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass
AT suzukieiji prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass
AT nagatamayumi prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass
AT suzukikeisuke prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass
AT hiratakoichi prophylactictreatmentforpatientswithmigraineusingbluecutfornightglass